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Abstract
Background: Recent evidence suggests that less than one-quarter of patients with symptomatic nosocomial Clostridium
difficile infections (CDI) are linked to other in-patients. However, this evidence was limited to one geographic area. We
aimed to investigate the level of symptomatic CDI transmission in hospitals located across England from 2008 to 2012.
Methods: A generalized additive mixed-effects Poisson model was fitted to English hospital-surveillance data. After
adjusting for seasonal fluctuations and between-hospital variation in reported CDI over time, possible clustering
(transmission between symptomatic in-patients) of CDI cases was identified. We hypothesised that a temporal proximity
would be reflected in the degree of correlation between in-hospital CDI cases per week. This correlation was modelled
through a latent autoregressive structure of order 1 (AR(1)).
Findings: Forty-six hospitals (33 general, seven specialist, and six teaching hospitals) located in all English regions met our
criteria. In total, 12,717 CDI cases were identified; seventy-five per cent of these occurred .48 hours after admission. There
were slight increases in reports during winter months. We found a low, but statistically significant, correlation between
successive weekly CDI case incidences (phi = 0.029, 95%CI: 0.009–0.049). This correlation was five times stronger in a
subgroup analysis restricted to teaching hospitals (phi = 0.104, 95%CI: 0.048–0.159).
Conclusions: The results suggest that symptomatic patient-to-patient transmission has been a source of CDI-acquisition in
English hospitals in recent years, and that this might be a more important transmission route in teaching hospitals.
Nonetheless, the weak correlation indicates that, in line with recent evidence, symptomatic cases might not be the primary
source of nosocomial CDI in England.
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Introduction
Clostridium difficile infection (CDI) is a source of considerable
morbidity and mortality for hospitalised patients, and its preven-
tion, control and treatment place a substantial burden on
healthcare systems[1,2]. Since 2007, in addition to improved
antimicrobial stewardship and mandatory surveillance, enhanced
infection control measures to prevent C. difficile transmission have
been implemented in England. These measures have focused on
isolating symptomatic patients and improving hospital-cleaning
regimens, with the goal of meeting government-led CDI reduction
targets. Reported cases of CDI have dropped from 55,498 in
2007/08 to 18,005 in 2011/12[3], at a time when the prevalence
of the hyper-virulent C. difficile BI/NAP1/027 also decreased[4].
Apart from improved antimicrobial stewardship, guidelines for
CDI prevention and control assume that symptomatic patients in
hospitals account for most C. difficile transmission and consequent
infection (CDI). However, in 2012 and 2013, research using whole
genome sequencing of hospital and community isolates from
Oxfordshire, United Kingdom, has challenged this assumption.
Eyre et al found a high level of genomic diversity in samples from
symptomatic CDI patients. Moreover, only a minority of hospital-
onset cases of CDI were found to share an epidemiological link as
well as genomic link with a symptomatic CDI case[5–7].
This recent evidence was limited to a small sample of hospitals
that were all located in one English county. To explore whether
these new developments in our understanding of the epidemiology
of CDI are more generally applicable, we investigated the
presence of clustering in symptomatic CDI patients, indicative of
patient-to-patient C. difficile transmission, in a wide range of
hospitals in England between 2008 and 2012.
PLOS ONE | www.plosone.org 1 June 2014 | Volume 9 | Issue 6 | e99860
Methods
Data
The dataset consisted of mandatory reported details of each
identified CDI case .2 years of age collected from all 167
National Health Service (NHS) Trusts via a web-enabled
surveillance system, held by Public Health England (PHE)[8].
Details included the dates of admission and faecal sampling,
patient category (e.g. inpatient, outpatient etc.) and age. Data
covering the period between April 2008 and March 2012 were
extracted from this surveillance scheme. To ensure consistency in
the reported observations, we restricted our analyses to NHS acute
trusts that followed the Department of Health’s CDI testing
guidance according to a survey held in 2010[9]. In England, a two
test screening algorithm has been advocated and hospital trusts are
recommended to test patients with diarrhoea (Bristol Stool Chart
types 5–7)[10] using either a GDH Enzyme Immunoassay (GDH
EIA), a nucleic acid amplification test (NAAT) or the Polymerase
Chain Reaction (PCR), followed by a toxin sensitive EIA (or a cell
cytotoxin neutralisation assay). If both the first test and the second
test are positive, the case is eligible for reporting to PHE[11]. This
resulted in the selection of data from 46 hospitals, belonging to 28
individual NHS acute Trusts, and excluded any of the Oxfordshire
hospitals (see table 1). Only CDI positive in-patients were included
for analysis (i.e. excluding regular attendees, outpatients and
patients having visited only accident and emergency departments).
In order to evaluate healthcare facility associated infections,
patients with onset of symptoms ,48 hours after admission were
excluded[12]. We aggregated the reported data per hospital by
week, using the date of faecal sampling as the time of onset of CDI
related symptoms.
Statistical methods
A generalized additive mixed-effects Poisson model, allowing for
overdispersion, with a log link[13,14], was used for the weekly
observations of CDI counts. Three effects were identified that
required inclusion in the linear predictor of this model. Firstly,
hospital was introduced as a categorical variable to allow for
potentially strong clustering due to differences in size, case-mix,
and region (see table 1). Secondly, a fixed polynomial-by-hospital
interaction term was included to accommodate varying rates of
change (primarily decline) over the four-year period in observed
CDI per hospital; Figure 1 shows the time series of symptomatic
CDI per hospital. Thirdly, a cyclic effect was included using a
periodic penalised cubic regression spline to accommodate
seasonal patterns of CDI, as have been observed previously in
settings outside England, and which have been attributed to
increased levels of ‘‘at risk" antibiotic use (e.g. ciprofloxacin)
during the winter months (January to March), and influenza
(which can lead to secondary bacterial infections requiring
antibiotic treatment)[15–17]. The intention was that these three
terms would account for the longitudinal behaviour of weekly CDI
counts. Finally, a random error term was added to the linear
predictor with an autoregressive correlation structure of order 1
(AR(1)) that would accommodate local (in time) departures from
this base model. The autoregressive component of this error would
be an indicator of local statistical dependence, and its presence
would serve as a proposed marker for transmission between
symptomatic cases (either directly, or indirectly via the hands of
healthcare works or hospital surfaces contaminated by symptom-
atic cases). Full details of the model are provided in the material
S1.
All analyses were performed with R 3.0.1 (Team R Develop-
ment Core, website: http://cran.r-project.org/) using the R
package mgcv[18] and splines. To account more accurately for the
decline in observed CDI since 2007, the comparative fit of three
polynomials, linear, quadratic and cubic was assessed using Akaike
Information Criterion (AIC). We added a cyclic (periodic)
penalised cubic regression spline over the variable week of the
year and compared model fit with and without this smoothing
term representing seasonal variations, again based on AIC (see
table S1). The standardized residuals were examined for significant
departures from normality[19]. In addition, the Box-Pierce
portmanteau statistic was used to indicate serial dependence.
Table 1. Description of CDI data from 46 selected hospitals.
N
Median/Mean for 4
year period
IQR
(Q1-Q3)
Median/Mean
p.w.
IQR
(Q1-Q3)
Cases per 10,000 bed-days
available (mean/median)
Number of weeks 209 - - - - -
Beds available per
hospital
- 422/423 243–515 - - -
General (n = 33) - 444/416 346–500 - - -
Teaching (n = 6) - 837/754 799–941 - - -
Specialist (n = 7) - 134/169 95–243 - - -
CDI cases reported 12,717 244/276 138–377 1/1.3 0-2 4.1/4.6
General 8,974 (70.6%) 253/272 194–352 1/1.3 0-2 4.1/4.5
Teaching 3,348 (26.3%) 551/558 331–690 2/2.7 1-4 5.6/6.4
Specialist 395 (3.1%) 37/56 30–77 0/0.27 0-0 1.8/3.1
CDI cases reported with
onset .48 h
9,574 184/208 104–270 1/1.0 0-1 3.1/3.5
General 6,779 (70.8%) 200/205 140–247 1/1.0 0-2 3.2/3.5
Teaching 2,504 (26.2%) 370/417 252–534 1/2.0 0-3 4.1/5.3
Specialist 291 (3.0%) 31/42 28–53 0/0.2 0-0 1.2/2.2
Summary statistics of CDI cases reported to the English mandatory surveillance system by a selection of 46 hospitals from the period of April 2008 to March 2012.
IQR = Interquartile range; p.w. = per week.
doi:10.1371/journal.pone.0099860.t001
Nosocomial Transmission of C. difficile in English Hospitals
PLOS ONE | www.plosone.org 2 June 2014 | Volume 9 | Issue 6 | e99860
Results
Descriptive statistics
The 46 hospitals reported 12,717 CDI cases in the four-year
study period, of which 9,574 (75.3%) had an onset.48 hours after
admission. Between 2008/09 and 2009/10 there was a 30.6%
decline in CDI reported from these healthcare facilities, in
comparison to 20.9% (2009/10 to 2010/11) and 15.7% (2010/
11 to 2011/12) in the years thereafter. This is in line with national
figures (29.1%, 18.0% and 17.1% respectively). Teaching hospitals
reported the highest number of cases, which did not change once
adjusted for their larger hospital size (expressed in the median
number of cases per 10,000 bed-days available, where available
bed-days is a crude estimate of the number of hospital beds in
2013[20] multiplied by the number of days covered by the study,
see table 1).
Base-model assuming no transmission patterns
For all three representations of the base-model, a model
including seasonal patterns provided a moderately better fit, and a
combination of seasonality and a cubic time trend proved the best
model fit (see table S1). By examining the correlogram of the final
base-model’s normalized residuals, we could identify whether
there was evidence of serial dependence (see figure 2A). Such
dependence could be explained by transmission between symp-
tomatic CDI carriers. Figure 2A illustrates a low but significant
correlation between cases in a given week and symptomatic
carriers present in the hospital one and two weeks earlier (p,0.05),
with a slightly stronger correlation at two weeks. Taking a total of
a 20-week interval (as transmission events between hospital cases
with an onset further than 20 weeks apart is assumed to be
unlikely), the model revealed a highly significant Box-Pierce Q-
statistic (X2= 54.59, degrees of freedom (df) = 20, p = 0.00005),
indicating non-independence. Therefore, the AR(1)-model was
fitted, with the best fitting cubic polynomial to represent the
decline in CDI over time, as well as seasonality.
AR(1)-model assuming transmission patterns
Figure S1 presents the seasonal variation of CDI in hospitals
within our sample fitted by the AR(1)-model, and shows a slight
increase during the months January to March. Assuming that
symptomatic cases primarily caused acquisition among patients
admitted to hospital up to one week later and, to a lesser extent, to
cases admitted beyond this time (i.e. the AR-1 structure), the
estimated magnitude of dependence was low, but statistically
significant (W=0.029 (95% CI= 0.009-0.049). This suggested that
transmission between symptomatic CDI cases was affecting the
weekly-observed CDI, but that its role in acquisition might be
limited. This transmission pattern between observed weekly CDI
was not fully explained by the AR(1) structure, as is indicated by
the significant correlation at lag(week) 2 still being present after
having fitted the AR(1) covariance structure (Box-Pierce Q-statistic
(X2 = 44.4, df = 20, p-value = 0.001)) (see figure 3A).
AR(1)-model by hospital type
The negative correlation presented in the AR(1) cubic model
after week 20 (see figure 3A) implied that the model might be over-
fitting our data. Also, diagnostic plots suggested deviation from
normality in the model’s standardized residuals (see figure S2A).
This can be explained by the large variability in the number of
reported cases per hospital, with a much greater number of reports
and related rate of change in reports over time from teaching
hospitals compared to just a few cases from specialist and some
general hospitals. As a consequence, a hospital-specific term in the
model representing the change in CDI reports over time might not
be suitable for hospitals with only a few cases reported, whereas
such specification is required to represent the CDI trend in
teaching hospitals. Fitting the model to the more homogeneous
Figure 1. Observed weekly number of CDI per hospital over the four-year study period. Grey dots represent the weekly-observed CDI
cases within all hospitals from April 2008 to March 2012. X-axis: Week 0 corresponds to the first week of April 2008 and week 209 to the last week of
March 2012. Red line: the incidence trend over time illustrated by cubic smoothing spline fit (for illustration).
doi:10.1371/journal.pone.0099860.g001
Nosocomial Transmission of C. difficile in English Hospitals
PLOS ONE | www.plosone.org 3 June 2014 | Volume 9 | Issue 6 | e99860
group of teaching hospitals only, revealed a stronger, but still
relatively low statistically significant correlation between CDI cases
and patients present in the hospital one week later (W=0.104
(95% CI= 0.048-0.159) (see figure 2B), which was captured by the
AR(1)-structure (Box-Pierce Q-statistic X2 = 23.2, df = 20,
p = 0.281) (see figure 3B). Figure 4 illustrates the cubic AR(1) model
predictions in comparison to the observed teaching hospital data
and figure S2 the model diagnostics.
Figure 2.Dependence between observed weekly number of CDI – base-model. A and B: autocorrelation function (ACF) of normalized
residuals of the base-model fitted to data of all hospitals (A) and of teaching hospitals only (B) including a fitted cubic representation of the CDI trend
over time and seasonality. The blue lines correspond to the threshold for significance of correlation (dependence) (p,0.05) between lagged weekly
observations up to week 20. E.g. crossing of this threshold by the base-model residuals at lag 1 and lag 2 for the model fitted to all hospitals suggests
that a correlation exists between the observed CDI in a given week and the number of CDI cases present in the hospital one and two weeks earlier.
doi:10.1371/journal.pone.0099860.g002
Figure 3. Dependence between observed weekly number of CDI – AR1-model. A and B: autocorrelation function (ACF) of normalized
residuals of the AR1-model fitted to data of all hospitals (A) and of teaching hospitals only (B) including a fitted cubic representation of the CDI trend
over time and seasonality. As in figure 2, the blue lines correspond to the threshold for significance of correlation (dependence) (p,0.05) between
lagged weekly observations up to week 20. Crossing of this threshold by the AR1-model residuals at lag 2 suggests the AR1 structure (symptomatic
cases primarily cause acquisition of C. difficile among patients admitted to hospital up to one week later and, to a lesser extent, to cases admitted
beyond this time), does not fully explain the dependence structure between weekly observations.
doi:10.1371/journal.pone.0099860.g003
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Discussion
In this study we explored the significance of symptomatic
patient-to-patient CDI transmission in English hospitals as a
source of hospital onset CDI. We found a statistical significant
signal of dependence between symptomatic CDI patients spending
time in hospital close in time, which suggested symptomatic
patient-to-patient transmission of CDI was present. Nonetheless,
the low magnitude of correlation between weekly cases in the
AR(1) model, implies that the role of symptomatic carriers in CDI-
acquisition was not as important as previously supposed. The
highest number of CDI cases was reported in teaching hospitals,
which corresponded to their overall prevalence of hospital-
acquired infections (HAI) being among the highest according to
the English National Point Prevalence Survey on HAI [8]. This
could be attributed to the more vulnerable case-mix of such
hospitals, whom might be more prone to acquiring CDI[21].
Taking CDI reports from the teaching hospitals only, the
association between symptomatic carriers was somewhat stronger,
but still relatively low. Our findings are in line with recent
evidence from whole genome sequencing of 1223 isolates from
healthcare (among others from two large acute teaching hospitals,
one specialist and one general district hospital) and community
onset CDI cases in Oxfordshire, England isolated from 2008 to
2011[7]. Less than 20% of the genetically linked CDI positive
cases had documented hospital contact with a symptomatic
patient[7]. In addition, 45% of the included CDI cases could
not be related to any other symptomatic case (community or
healthcare setting) as they were too genetically diverse[7]. Even
considering the reported low sensitivity of the toxin EIA test[12]
used for CDI identification in the referenced study, the diversity
argues for alternative sources of many CDI cases.
Improved infection control, with a primary focus on preventing
transmission, such as hand hygiene, isolation of symptomatic cases,
and environmental cleaning, might result in lower rates of
successful transmission between symptomatic cases following
contact[22]. In addition, once a patient comes in contact with C.
difficile or its spores, the development of CDI is dependent on the
disruption of the normal gut flora, primarily due to antibiotic use
such as broad-spectrum cephalosporins and quinolones[23,24].
Nonetheless, this would not explain the origin of symptomatic
patients lacking a shared spatial-temporal and/or genetic link. C.
difficile has been recovered from hospital rooms occupied by both
symptomatic and asymptomatic carriers[25–27] and its spores can
persist in the environment for as long as 20 weeks[28]. Therefore,
transmission from contaminated hospital surfaces could suggest
symptomatic hospital cases are unrelated, whereas actually
indirect-cross infection could have occurred. However, a genetic
link would still be found if cases had acquired their infection from
the same contaminated hospital surface. If no restrictions were
applied to the infectious period, incubation period or length of
ward contamination, 27% of the sequenced samples in the earlier
mentioned study shared both a genetic and an epidemiological
hospital contact [7]. Alternatively, asymptomatic carriers could
contaminate hospital surfaces with lower intensity than symptom-
atic carriers, hence cause acquisition at low frequency, which
could potentially explain the wide genomic diversity among cases
[29].
Importation of symptomatic and asymptomatic carriers from
community-settings such as long-term care facilities (LTCF) has
also been suggested as a source for hospital-onset CDI[30,31]. A
population-based study conducted in the United States showed
that out of a total of 416 identified CDI cases, 41% had onset of
symptoms in the community or within 48 hours after admission
and no hospitalisation in the 12 weeks prior to onset[32]. We
excluded patients with an onset of CDI ,48 hours into admission.
This is a frequently used, but arbitrary, cut-off to define
community-acquired HAI. Hence it is possible that our data
included asymptomatic patients who acquired the bacteria
elsewhere, and developed symptoms in the hospital .48 hours
after admission. Moreover, in addition to onset within 48 hours
into admission, no hospitalisation in the past 12 weeks is an often-
used additional requirement for community-acquired CDI [11].
As we did not have information on previous hospitalisation, the
possibility exists that cases defined as community-acquired in our
data, and were therefore excluded, actually were hospital-acquired
cases, i.e. patients who acquired C. difficile in their previous stay,
but started to develop symptoms after discharge and were re-
admitted with symptomatic CDI. Furthermore, approximately
20% of cases with a first occurrence of CDI experience recurrence
after discontinuation of treatment[33,34]. Re-admitted CDI
carriers, who resolved their symptoms but remained colonised
resulting in a recurrent episode once e.g. put on at risk antibiotics,
could be partly responsible for the low correlation between
symptomatic carriers. However, considering the known chances of
relapse, we do not expect these can be primarily responsible for the
results of this study.
Finally, and although not our primary focus, we found evidence
of seasonal variations in CDI incidence in our selection of English
hospitals, with slightly elevated reports of hospital-associated
symptomatic CDI in the winter months. Seasonality has been
suggested in relation to increased levels of CDI related antibiotics
during the winter months in settings outside of England[15–17].
Figure 4. AR(1) model fit teaching hospitals. Grey dots represent the weekly-observed CDI cases within the teaching hospitals from April 2008
to March 2012. X-axis: Week 0 corresponds to the first week of April 2008 and week 209 to the last week of March 2012. Blue line: fit of the AR(1)
model with a cubic representation of the rate of change of CDI over time and seasonality.
doi:10.1371/journal.pone.0099860.g004
Nosocomial Transmission of C. difficile in English Hospitals
PLOS ONE | www.plosone.org 5 June 2014 | Volume 9 | Issue 6 | e99860
Comparison of variability in antibiotic prescribing patterns within
English hospitals with fluctuations in hospital reported CDI
incidence would be an interesting area of investigation. Nonethe-
less, the seasonal component in our model only explained a small
proportion of the behaviour of the weekly reported CDI (reflected
by a moderate decrease of AIC), and we would like to urge for
more research on the presence of seasonal patterns of CDI in
England.
This study had several limitations. Firstly, we selected weekly
intervals for our analysis. Both the incubation time and infectious
period of C. difficile have not been quantified with certainty. Studies
have suggested that person-to-person transmission occurs primar-
ily within a week (ranging from a median of 1, 4 or 8 days after
CDI diagnosis)[5], whereas a median incubation time of 2-3
days[12] to 18–33 days has been proposed[5]. Hence, onset of
symptoms following symptomatic patient-to-patient transmission
might occur after the one-week time interval, which could have
affected the strength of correlation between weekly incidences.
Secondly, strains may vary in their pathogenicity[35] and
transmissibility[6]. The routinely collected surveillance data did
not contain ribotype specific information, so we could not establish
to what extent our results are strain-specific as well as whether the
hospitals in our sample are representative with regards to strain
prevalence. Moreover, the AR1 structure was unable to fully
explain the correlation between weekly cases close in time using
data from all hospital types, whereas it could for the teaching
hospitals only. This might be a consequence of the stochastic
nature of the few CDI cases reported by the smaller hospitals
included in the overall dataset. Alternatively, teaching hospitals
might have better environmental cleaning practices in place and/
or are more likely to change antibiotic prescribing practices
following an outbreak, resulting in more rapid containment.
Further research is needed to clarify the observed heterogeneity in
reported hospital-acquired infection rates and transmission
between teaching and non-teaching hospitals. Finally, alternative
causes of dependence of the weekly CDI observations cannot be
ruled out, e.g. a Scottish study[36] identified a temporal
correlation between antibiotic use and HA-CDI [36]. However,
as the results of the referenced study[36] suggest, it is unlikely that
antibiotic hospital consumption will fluctuate between weekly time
intervals. After investigation of the association between monthly
variations in antibiotic use and monthly variations in observed
CDI, Vernaz and colleagues (2009) identified that, for almost all of
the antibiotics investigated, the association with observed CDI was
significant with a lag of several months (among others ciproflox-
acin, fluoroquinolones and cefuroxime) [36]. In addition, cases
arising from asymptomatic carriers or environmental sources
might correlate in space and time as well. However, the level of
onward transmission from asymptomatically colonised individuals
is highly uncertain, nor has foodborne transmission of C. difficile to
humans been established with certainty [37,38]. Given the
infectious nature of symptomatic C. difficile cases, especially in
settings with high antibiotic use, we expect symptomatic patient-
to-patient transmission to be the most conservative explanation.
Despite the limited information present in routinely collected
hospital infection data, this study has provided further insight in
the hospital transmission dynamics of C. difficile. Our results
indicate that patient-to-patient transmission when only those
patients with symptomatic CDI are considered, may account for a
small number of transmission events. To improve our under-
standing of the epidemiology of CDI, the role of other patient
groups should be considered, such as those in the community and
asymptomatic carriers, as well as the importance of indirect
transmission from contaminated surfaces in the hospital environ-
ment and the role of antibiotic use. Individual-level patient data,
which can inform dynamic transmission models would certainly
aid the investigating and quantification of the potential sources of
CDI transmission[39–41] and will be another area of our further
investigations.
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Figure S1 Seasonal variations of symptomatic C. diffi-
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Fitted cyclic penalised cubic regression spline (representing
seasonal variations) for the cubic AR(1) model fitted to data of
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Figure S2 Diagnostic plots cubic AR(1)-models. A:
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distribution.
(DOCX)
Acknowledgments
We would like to thank Simon Goldenberg for sharing data on testing
algorithm used in NHS hospital trusts. Also, we thank Mike Kenward, and
Nathan Green for providing useful insights and helpful discussions on the
statistical methods applied.
Author Contributions
Conceived and designed the experiments: EvK AG WJE SRD MJ JVR.
Performed the experiments: EvK AG. Analyzed the data: EvK.
Contributed reagents/materials/analysis tools: EvK AG RG BC RH MJ
JVR SRD WJE. Contributed to the writing of the manuscript: EvK MJ
JVR SRD WJE.
References
1. Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW (2010) Economic
healthcare costs of Clostridium difficile infection: a systematic review. Journal of
Hospital Infection 74: 309–318.
2. Dubberke ER, Olsen MA. (2012) Burden of Clostridium difficile on the
Healthcare System. Clinical Infectious Diseases 55: S88–S92. doi:10.1093/cid/
cis335.
Nosocomial Transmission of C. difficile in English Hospitals
PLOS ONE | www.plosone.org 6 June 2014 | Volume 9 | Issue 6 | e99860
3. Public Health England (former Health Protection Agency) (2012) Mandatory
surveillance of Clostridium difficile. PHE website. Available: http://www.hpa.
org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1179746015058. Ac-
cessed 2013 Mar 20.
4. Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, et al. (2012) Changing
Epidemiology of Clostridium difficile Infection Following the Introduction of a
National Ribotyping-Based Surveillance Scheme in England. Clinical infectious
diseases 55. doi:10.1093/cid/cis614.
5. Walker a S, Eyre DW, Wyllie DH, Dingle KE, Harding RM, et al. (2012)
Characterisation of Clostridium difficile Hospital Ward-Based Transmission
Using Extensive Epidemiological Data and Molecular Typing. PLoS medicine 9:
e1001172. doi:10.1371/journal.pmed.1001172.
6. Didelot X, Eyre D, Cule M, Ip C, Ansari A, et al. (2012) Microevolutionary
analysis of Clostridium difficile genomes to investigate transmission. Genome
Biology 13: R118. doi:10.1186/gb-2012-13-12-r118.
7. Eyre DW, Cule ML, Wilson DJ, Griffiths D, Vaughan A, et al. (2013) Diverse
Sources of C. difficile Infection Identified on Whole-Genome Sequencing. New
England Journal of Medicine 369: 1195–1205. doi:10.1056/NEJMoa1216064.
8. Public Health England (former Health Protection Agency) (2012) English
National Point Prevalence Survey on Healthcare-associated Infections and
Antimicrobial Use, 2011 - preliminary data. London.
9. Goldenberg SD, French GL (2011) Diagnostic testing for Clostridium difficile: a
comprehensive survey of laboratories in England. The Journal of hospital
infection 79: 4–7. doi:10.1016/j.jhin.2011.03.030.
10. Lewis S, Heaton K (1997) Stools form scale as a usefule guide to intestinal transit
time. Scandinavian Journal of Gastroenterology 32: 920–924.
11. Department of Health (2012) Updated guidance on the diagnosis and reporting
of Clostridium difficile.
12. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, et al. (2010) Clinical
practice guidelines for Clostridium difficile infection in adults: 2010 update by
the society for healthcare epidemiology of America (SHEA) and the infectious
diseases society of America (IDSA). Infection control and hospital epidemiology
31: 431–455. doi:10.1086/651706.
13. Goldstein H (2010) Multilevel Statistical Models. 4th ed. Chichester: Wiley-
Blackwell.
14. Snijder TAB, Bosker RJ (2012) Multilevel analysis: An introduction to basic and
advanced multilevel modeling. 2nd ed. London, England: SAGE publications.
15. Archibald LK, Banerjee SN, Jarvis WR (2004) Secular trends in hospital-
acquired Clostridium difficile disease in the United States, 1987–2001. The
Journal of infectious diseases 189: 1585–1589.
16. Polgreen P, Yang M, Bohnett L, Cavanaugh J (2010) A Time-Series Analysis of
Clostridium difficile and Its Seasonal Association with Influenza. Infection
Control Hosp Epidemiol 31: 382–387. doi:10.1086/651095.A.
17. Gilca R, Fortin E, Frenette C, Longtin Y, Gourdeau M (2012) Seasonal
variations in Clostridium difficile infections are associated with influenza and
respiratory syncytial virus activity independently of antibiotic prescriptions: a
time series analysis in Quebec, Canada. Antimicrobial agents and chemotherapy
56: 639–646. doi:10.1128/AAC.05411-11.
18. Wood SN (2006) Generalized Additive Models: an introduction with R. 1st ed.
London: Chapman and Hall/CRC.
19. Pinheiro JC, Bates DM (2000) Mixed-Effects Models in S and S-PLUS. New
York: Springer.
20. Intelligence dr F (2013) Hospital guide. Available: http://www.drfosterhealth.
co.uk/hospital-guide/.
21. So¨derlund N, Milne R, Gray A, Raftery J (1995) Differences in hospital casemix,
and the relationship between casemix and hospital costs. Journal of public health
medicine 17: 25–32.
22. Hsu J, Abad C, Dinh M, Safdar N (2010) Prevention of endemic healthcare-
associated Clostridium difficile infection: reviewing the evidence. American
Journal of Gastroenterology 105: 2327–39; quiz 2340.
23. Starr JM, Martin H, McCoubrey J, Gibson G, Poxton IR (2003) Risk factors for
Clostridium difficile colonisation and toxin production. Age and ageing 32: 657–
660.
24. Thomas C, Stevenson M, Riley TV (2003) Antibiotics and hospital-acquired
Clostridium difficile-associated diarrhoea: a systematic review. Journal of
Antimicrobial Chemotherapy 51: 1339–1350.
25. McFarland LV, Mulligan ME, Kwok RYY, Stam WE (1989) Nosocomial
acquisition of Clostridium difficile infection. New England Journal of Medicine
321: 190.
26. Samore MH, Venkataraman L, Degirolami PC, Arbeit RD, Karchmer AW
(1996) Clinical and Molecular Epidemiology of Sporadic and Clustered Cases of
Nosocomial Clostridium difficile Diarrhea. the American Journal of Medicine
100: 32–40.
27. Kaatz G, Gitlin S, Schaberg D, Wilson KH, Kauffman CA, et al. (1988)
Acquisition of clostridium difficile from the hospital environment. American
Journal of Epidemiology 127: 1289–1294.
28. Kim K, Fekety R, Batts DH, Brown D (1981) Isolation of Clostridium difficile
from the Environment and Contacts of Patients with Antibiotic-Associated
Colitis. The Journal of infectious diseases 143: 42–50.
29. Guerrero DM, Becker JC, Eckstein EC, Kundrapu S, Deshpande A, et al. (2013)
Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients.
The Journal of hospital infection: 2–5. doi:10.1016/j.jhin.2013.07.002.
30. Ricciardi R, Nelson J, Griffith JL, Concannon TW (2012) Do admissions and
discharges to long-term care facilities influence hospital burden of Clostridium
difficile infection? The Journal of hospital infection 80: 156–161. doi:10.1016/
j.jhin.2011.11.002.
31. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RLP, et al. (2007)
Asymptomatic Carriers Are a Potential Source for Transmission of Epidemic
and Nonepidemic Clostridium difficile Strains among Long-Term Care Facility
Residents. Clinical Infectious Diseases 45: 992–998. doi:10.1086/521854.
32. Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, et al. (2011) The
Epidemiology of Community-Acquired Clostridium diffi cile Infection: A
Population-Based Study. The American Journal of Gastroenterology 107: 89–
95. doi:10.1038/ajg.2011.398.
33. Kamboj M, Khosa P, Kaltsas A, Babady NE, Son C, et al. (2011) Relapse versus
reinfection: surveillance of Clostridium difficile infection. Clinical infectious
diseases 53: 1003–1006. doi:10.1093/cid/cir643.
34. Fekety R, McFarland L V, Surawicz CM, Greenberg RN, Elmer GW, et al.
(1997) Recurrent Clostridium difficile diarrhea: characteristics of and risk factors
for patients enrolled in a prospective, randomized, double-blinded trial. Clinical
infectious diseases: an official publication of the Infectious Diseases Society of
America 24: 324–333.
35. Walker AS, Eyre DW, Wyllie DH, Dingle KE, Griffiths D, et al. (2013)
Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in
Clostridium difficile Infection. Clinical infectious diseases 56: 1589–1600.
doi:10.1093/cid/cit127.
36. Vernaz N, Hill K, Leggeat S, Nathwani D, Philips G, et al. (2009) Temporal
effects of antibiotic use and Clostridium difficile infections. The Journal of
antimicrobial chemotherapy 63: 1272–1275. doi:10.1093/jac/dkp128.
37. Eyre DW, Griffiths D, Vaughan A, Golubchik T, Acharya M, et al. (2013)
Asymptomatic Clostridium difficile colonisation and onward transmission. PloS
one 8: e78445. doi:10.1371/journal.pone.0078445.
38. Gould LH, Limbago B (2010) Clostridium difficile in food and domestic animals:
a new foodborne pathogen? Clinical infectious diseases: an official publication of
the Infectious Diseases Society of America 51: 577–582. doi:10.1086/655692.
39. Bootsma MCJ, Bonten MJM, Nijssen S, Fluit a C, Diekmann O (2007) An
algorithm to estimate the importance of bacterial acquisition routes in hospital
settings. American journal of epidemiology 166: 841–851. doi:10.1093/aje/
kwm149.
40. McBryde ES, Pettitt AN, Cooper BS, McElwain DLS (2007) Characterizing an
outbreak of vancomycin-resistant enterococci using hidden Markov models.
Journal of the Royal Society Interface 4: 745–754.
41. Forrester ML, Pettitt AN, Gibson GJ (2007) Bayesian inference of hospital-
acquired infectious diseases and control measures given imperfect surveillance
data. Biostatistics 8: 383–401.
Nosocomial Transmission of C. difficile in English Hospitals
PLOS ONE | www.plosone.org 7 June 2014 | Volume 9 | Issue 6 | e99860
